| Autor: |
Jacopo Mariotti, Paolo Corradini, Anisa Bermema, Davide Confalonieri, Camilla Recordati, Antonio Vendramin, Silvia Gimondi, Cristiana Carniti |
| Rok vydání: |
2023 |
| DOI: |
10.1158/1078-0432.22457555 |
| Popis: |
Supplementary Figures S1-6. Figure S1: Histological staging criteria for acute GvHD Figure S2: Ruxolitinib does not impair post-transplant donor myeloid reconstitution and full donor chimerism. Figure S3: GVT effect against myeloid leukemia RMB-1 cell line is maintained in the presence of ruxolitinib Figure S4: Ruxolitinib at the dose of 90 mg/Kg prevents acute GVHD without affecting T cell alloreactivity Figure S5: Ruxolitinib effect at 45 mg/Kg on absolute numbers of alloreactive T cells, Th17 and Treg cells. Figure S6: Representative Images of Ruxolitinb effect on T cells and macrophage infiltration of GVHD organs |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
